Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00920738 · ClinicalTrials.gov registry record
Metabolic Syndrome in Childhood Cancer Survivors
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 512
- Enrollment target
NCT00920738: Completed study, sponsored by University of Minnesota.
NCT00920738 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 512 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00920738 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 512 participants
- Enrollment target
Study Summary
RATIONALE: Gathering information about how often metabolic syndrome occurs in young survivors of childhood cancer may help doctors learn more about the disease. PURPOSE: This clinical trial is studying metabolic syndrome in survivors of childhood cancer and in their healthy sisters and brothers.
Interventions
- OTHER questionnaire administration
- OTHER metabolic assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 512 participants |
| Start Date | 2005-04 |
| Est. Completion | 2011-06 |
What the finished NCT00920738 record still lists
NCT00920738 is an observational study that tracks outcomes without assigning an intervention. The registered 512 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which questionnaire administration is the first listed.
NCT00920738 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00920738 about?
NCT00920738 is a clinical study titled "Metabolic Syndrome in Childhood Cancer Survivors". RATIONALE: Gathering information about how often metabolic syndrome occurs in young survivors of childhood cancer may help doctors learn more about the disease. PURPOSE: This clinical trial is studying metabolic syndrome in survivors of childhood cancer and in their healthy sisters and brothers.
What is the current status of trial NCT00920738?
This trial is currently completed. The enrollment target is 512 participants. The study started on 2005-04. Estimated completion is 2011-06.
What interventions are being tested in trial NCT00920738?
The interventions under investigation include: questionnaire administration (OTHER), metabolic assessment (OTHER).
Who is sponsoring clinical trial NCT00920738?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05005403 · 512 participants · Phase 1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab
- NCT05337410 · 512 participants · NA
YES: Innovative Discussion for Engagement, Achievement, and Service
- NCT06096259 · 512 participants · Phase 2
Preventing Injured Knees From osteoArthritis: Severity Outcomes
- NCT05691244 · 514 participants · Phase 3
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia